Background The mechanism of mucosal damage induced by ischemia-reperfusion (IR) after hemorrhagic shock is complex; mast cells (MC) degranulation is associated with the mucosal damage. Astragalus membranaceus can protect intestinal mucosa against intestinal oxidative damage after hemorrhagic shock, and some antioxidant agents could prevent MC against degranulation. This study aimed to observe the effects of astragalus membranaceus injection on the activity of intestinal mucosal mast cells (IMMC) after hemorrhage shock-reperfusion in rats Methods Thirty-two Wistar rats were randomly divided into the normal group, model group, low dosage group, (treated with Astragalus membranacaus injection, 10 g crude medication/kg) and high dosage group (treated with Astragalus membranacaus injection, 20 g crude medication/kg). The rat model of hemorrhagic shock-reperfusion was induced by hemorrhage for 60 minutes followed by 90 minutes of reperfusion. The animals were administrated with 3 ml of the test drug solution before reperfusion. At the end of study, intestinal pathology, ultrastructure of IMMC, and expression of tryptase were assayed. The levels of malondisldehyde (MDA), TNF-α, histamine, and superoxide dismutase (SOD) activity in intestine were detected, and the number of IMMC was counted. Results The Chiu's score of the rats in the model group was higher than in other groups (P<0.01). The Chiu's score in the high dosage group was higher than that in the low dosage group (P<0.05). Hemorrhage-reperfusion induced IMMC degranulation: Astragalus membranaceus injection attenuated this degranulation. Expression of tryptase and the number of IMMC in the model group increased compared with the other groups (P<0.01) and was significantly reduced by the treatments of Astragalus membranaceus injection at both doses. There was no significant difference between the two treatment groups (P>0.05). MDA content and concentration of TNF-α in the model group were higher than that in the other three groups (P<0.05), and the concentration of TNF-α in the low dosage group was higher than that in the high dosage group (P<0.05). SOD activity and the concentration of histamine in the model group were lower than the other three groups (P<0.05). There was a negative correlation between the Chiu's score and the concentration of histamine and a positive correlation between the Chiu's score and the concentration of TNF-α and between the SOD activity and the concentration of histamine in the four groups (P<0.05). Conclusion Astragalus membranaceus injection may reduce the damage to small intestine mucosa by inhibiting the activated IMMC after hemorrhagic shock.
Bacterial endotoxin can enter into blood across the barrier when the intestinal mucosal barrier is demolished due to anoxia, ischemic and reperfusion injury. Guo, 2 Pape, 3 and Mitsuoka 4 have proved that it is possible for these injures to induce systemic inflammatory response syndrome (SIRS) or multiple organ dysfunction syndrome (MODS), leading to the hemorrhagic shock.
Boros 5 reported that intestinal ischemia induced the release of a variety of intestinal mucosal mast cells (IMMC)-derived inflammatory compounds and resulted in a spectrum of injury ranging from reversible permeability changes to structural mucosal damage. Kim 6 found that Gallic acid, an antioxidant agents, could prevent mast cell degranulation. Astragalus membranaceus is a traditional Chinese medicine. Our study has demonstrated that Astragalus membranaceus can protect intestinal mucosa against intestinal oxidative damage after hemorrhagic shock. 7 The mechanism by which Astragalus membranaceus inhibits the activated IMMC after hemorrhagic shock is unknown. The main purpose of this study was to investigate whether Astragalus membranaceus prevented IMMC from degranulation in intestinal mucosal in response to damage induced by ischemiareperfusion.
METHODS

Animal experimental protocol
Thirty-two healthy Wistar rats (180-250 g), were provided by the Animal Center of Sun Yat-Sen University, China. This study was approved by the University Animal Study Committee. The rats were randomly divided into four groups: the normal group (n=8; sham-operated, no shock and no reperfusion occurred), the model group (n=8; hemorrhagic shock followed by reperfusion and treated with 3 ml normal saline intravenously prior to reperfusion), the low dose group (n=8; hemorrhagic shock followed by reperfusion and treated with a 10 g crude medication/kg astragalus membranaceus injection which was 5 times of the human clinical dose) and high dose group (n=8; hemorrhagic shock followed by reperfusion and treated with a 20 g crude medication/kg Astragalus membranaceus injection which was 10 times of the human clinical dose).
Astragalus membranaceus for injection was provided by Dioujiuhong Pharmaceutical Co., Ltd, Chengdu, China. One ml injection, which contains 2 g of crude medication Astragalus membranaceus, was diluted in 3 ml normal saline and infused intravenously 3 minutes prior to reperfusion.
Experimental model of hemorrhagic shock and resuscitation
Laboratory temperature was kept at 25-27˚C. The rats were anesthetized by intraperitoneal injection of sodium pentobarbital (45 mg/kg) after they were fasted for 18 hours. Tracheotomy was performed for ventilation. The right cervical vein was cannulated for monitoring central venous pressure and fluid infusion and drug delivery. The right carotid artery and femoral artery were catheterized for monitoring arterial pressure. The femoral artery was used to withdraw blood samples and to create the hemorrhagic shock model. 8 The hemorrhagic shock model was established by withdrawing blood from the femoral artery until the mean arterial blood pressure (MABP) reached about 5.3 kPa (40 mmHg) where it was maintained for 60 minutes.
The rats were given 3 ml solution/drugs. Then their blood was reinfused for approximately 5 minutes and they were observed for 90 minutes. The rats were killed and the segment samples of small intestine were taken at the end of the experiment.
Preparation of specimens and measurements
After successful establishment of the experimental model, the rats were killed and dissected rapidly. A segment of 0.5-1.0 cm of intestine was cut 5 cm from the terminal ileum, fixed in 4 % formaldehyde polymerisatum and embedded in paraffin for sectioning. Another segment of small intestine was washed with frozen saline, dried with suction paper and frozen at -70˚C.
The segment of small intestine was stained with hematoxylin-eosin. The damages to the intestinal mucosa was evaluated by the criteria of Chiu's method. Criteria of the Chiu grading system are divided into 5 subdivisions according to the changes of the villus and the glands of intestinal mucosa: 9 grade 0, normal mucosa; grade 1, development of subepithelial Gruenhagen's space at the tip of villus; grade 2, extension of the space with moderate epithelial lifting; grade 3, massive epithelial lifting with a few denuded villi; grade 4, denuded villi with exposed capillaries; and grade 5, disintegration of the lamina propria, ulceration and hemorrhage.
Transmission electron microscopy
Intestines were immersion fixed in 2.5% glutaraldehyde overnight at 4˚C, washed three times in PBS, then postfixed in aqueous 1% OsO 4 , 1% K 3 Fe(CN) 6 for 1 hour. After three PBS washes, the tissue was dehydrated through a graded series of 30 % to 100 % ethanol washes, 100% propylene oxide, then infiltrated in a 1:1 mixture of propylene oxide-Polybed 812 epoxy resin for 1 hour. After several changes of 100% resin throughout 24 hours; the tissue was embedded in molds, cured at 37˚C overnight, followed by additional hardening at 65˚C for 2 more days. Ultrathin (70 nm)sections were collected on 200-mesh copper grids, stained with 2% uranyl acetate in 50% methanol for 10 minutes, followed by 1% lead citrate for 7 minutes. Sectionswere photographed using a Hitachi H-600 transmission electron microscope (TOSHIBA, Japan) at 80 kV onto electron microscope film.
Detection of concentration of protein in intestine
Intestinal protein was measured according to the manufacturer's instructions using kits were provided by Shenerg Biocolor BioScience & Technolgy Company, Shanghai, China.
Detection of content of malondisldehyde (MDA) in the intestine
Intestinal tissues were homogenized with normal saline. MDA content was determined by the TBA method (Jiancheng Bioengineering Ltd, Nanjing, China). Homogenate (0.1 ml) was taken to detect MDA content. Briefly, 0.1 ml 8.1% SDS, 0.8 ml acetic acid buffer, 0.8 ml 0.8% TBA and 0.2 ml distilled water were added into the sample tubes and one standard tube (containing 0.1 ml tetraethoxypropane). Then all the tubes were incubated at 100˚C for 1 hour. After cooled at -20˚C for 5 minutes, 2 ml of n-butyl alcohol was added into the sample, which was then vibrated for 1 minute and centrifuged for 10 minutes at 3 000 r/min. The supernatant of the samples were assayed to detect absorbance at 532 nm; and results were expressed as nmol/ml. The content of MDA in intestine was calculated as mmol/mg protein.
Detection of activity of superoxide dismutase (SOD) in the intestine
Intestinal tissues were made into a homogenate with normal saline, frozen at -20˚C for 5 minutes and centrifuged for 15 minutes at 4000 r/min. Supernatants were transferred into fresh tubes for evaluation of SOD activity. SOD activity was evaluated with an SOD detection kit according to the manufacturer's instructions (Kits were provided by Jiancheng Bioengineering Ltd, Nanjing, China). Results were expressed as nmol/ml. The activity of SOD in the intestine was calculated as U/mg protein.
Detection of concentration of TNF-α in the intestine
Intestinal tissues were made into a homogenate with normal saline, frozen at -20˚C for 5 minutes and centrifuged for 15 minutes at 4000 r/min. Supernatants were transferred into fresh tubes for evaluation of concentration of TNF-α (Biosource, USA) using a commercially available ELISA kit in accordance with the manufacturer's instructions, results were expressed as pg/ml. The concentration of TNF-α in the intestine was calculated as pg/mg protein.
Detection of concentration of histamine in the intestine
Intestinal tissues were made into a homogenate with normal saline, frozen at -20˚C for 5 minutes and centrifuged for 15 minutes at 4000 r/min. Supernatants were transferred into fresh tubes for evaluation of concentration of histamine (RapidBio Lab, USA) using a commercially available ELISA kit in accordance with the manufacturer's instructions, results were expressed as ng/ml. The concentration of histamine in the intestine was calculated as ng/mg protein.
Immunohistochemical detection of tryptase in the intestine
Five µm thick sections were prepared from paraffin-embedded tissue. After deparaffinization, endogenous peroxidase was quenched with 3% H 2 O 2 in deionised water for 10 minutes. Nonspecific binding sites were blocked by incubating the sections in 10% normal rabbit serum for 1 hour. The sections were then incubated with polyclonal rat anti-mast cell tryptase (dilution 1:50) for 30 minutes at 37˚C, followed by incubation with biotinylated goat-anti-rat IgG at room temperature for 10-15 minutes. After 3 ×5 minutes PBS rinses, the horseradish-peroxidaseconjugated streptavidin solution was added and incubated at room temperature for 10-15 minutes. The antibody binding sites were visualized by incubation with a diaminobenzidine-H 2 O 2 solution.
The sections incubated with PBS instead of the primary antibody were used as negative controls.
Brown-yellow granules in the cytoplasm were recognized as positive staining for tryptase. We calculated the tryptase positive mast cells and their intensity in 5 representative areas at × 400 magnification by Image-Pro Plus 5.0 (USA).
Statistical analysis
Data were expressed as mean±SD and analysis of variance was performed using SPSS 11.0 software. One-way analysis of variance was used for multiple comparison and least significant difference test (LSD-t) was used for intra-group comparison. A P value< 0.05 was considered statistically significant.
RESULTS
Changes of intestinal mucosa under light microscope
The villus and glands were normal and no inflammatory cell infiltration was observed in mucosal epithelial layer in the normal group. Severe edema of the mucosa villus and infiltration of necrotic epithelial and inflammatory cells were found in the model group, indicating that damage was severe. Light edema of the mucosa villus and infiltration of few necrotic epithelial inflammatory cells were found in the mucosa epithelial layer in the low dosage group. No significant edema and necrotic mucosa villus was observed, but infiltration of a few inflammatory cells into the mucosal epithelial layer were found in the high dosage group. This was the same histology as the normal intestinal mucosa (Fig. 1) .
Changes of ultrastructure of IMMC
The ultrastructure of IMMC was normal in the normal group. There were abundant vacuolus with a reduction granulation in their endochylema in the model group; and there were few swollen granules with a reduction in their homogeneity in the high and low dosage groups (Fig. 2 ).
Chiu's score of small intestinal structure
The Chiu's score of the normal group was the lowest while the model group had the highest score. Compared to the model group; the Chiu's score of the high dosage group was significantly lower (P<0.05, Table 1 ). 
Changes of MDA in small intestine
The content of MDA in the intestine of the model group was higher than that of the other three groups (P<0.05, Table 2 ).
Changes of activity of SOD in small intestine
The activity of SOD in the intestine of the normal group was the highest, and model group had the lowest SOD activity (P<0.05, Table 2 ).
Changes of TNF-α in small intestine
The concentration of TNF-α in the intestine of the model and the low dosage groups were higher than in the other two groups (P<0.05). There were no significant difference between the normal group and the high dosage group (P>0.05, Table 2 ). There was a positive correlation between the Chiu's score and the concentration of TNF-α in the four groups (r= 0.736, P<0.05).
Changes of histamine in small intestine
The concentration of histamine in the intestine of the model group was lowest (P<0.05); but there was no significant difference between the other three groups (P>0.05, Table 2 ). There was a negative correlation between the Chiu's score and the concentration of histamine(r=-0.544, P<0.05) and a positive correlation between the SOD activity and the concent ration of histamine in the four groups (r=0.495, P<0.05).
Counts and expression of tryptase of IMMC
Expression of tryptase and the number of IMMC in model group was higher than in the other three groups; and expression in the normal group was lower than in the other three groups (P<0.01). There was no significant difference between the high dosage group and the low dosage group (P>0.05, Fig. 3 and Table 2 ).
DISCUSSION
IMMCs are particularly frequent in close proximity to epithelial surfaces where they are strategically located for optimal interaction with the environment and for their putative functions in host defense. 10 There they sense the entry of foreign material into the mucosa and orchestrate an appropriate inflammatory response, which a component of the fourth level of mucosal defense. 11 Tryptase is one of the specific markers of IMMC. 12 Our research found that the expression of tryptase and IMMC counts significantly increased after ischemic-reperfusion, while IMMC were degranulated in the model group.
IMMC is the main source of histamine in the intestine. The level of intestinal histamine is determined by the intracellular and extracellular concentration of histamine from the IMMC. The level of intestinal histamine is mainly restricted to the concentration of histamine within IMMC as the histamine released from IMMC in the gastrointestinal tract is rapidly cleared and degraded. 13 The more IMMC degranulation, the lower the concentration of histamine found in intestine. 14 Our study found that the histamine level decreased significantly in the model group. The results suggest that the increase in the IMMC count, the degranulation of IMMC and the decrease in histamine level induced by ischemic-reperfusion may serve as clinic indicators.
Boros 15 demonstrated that the recruitment of leukocytes to areas of inflammation was a multistep process in which the initiation of slow rolling leukocytes by histamine stimulation was a precondition for subsequent firm adhesion and extravasation into the surrounding tissues. More specifically, neutrophil rolling is dependent on histamine. 16 Previous studies showed an important role of TNF-α in reperfusion-induced tissue injury and lethality, 17 and treatment of rats with anti-TNF-α antibodies prevented neutrophil influx, tissue injury and lethality after intestinal ischemia and reperfusion. 18 Frangogiannis 19 showed that mast cells were an important source of TNF-α and histamine during ischemia and reperfusion. Our research found that the intestinal histamine concentration decreased; and the intestinal TNF-α concentration increased after ischemic-reperfusion. There was a negative correlation between the Chiu's score and the concentration of histamine, and a positive correlation between the Chiu's score and the concentration of TNF-α, suggesting the essential role of histamine and TNF-α in ischemia-reperfusion injury.
IMMCs are located in close proximity to submucosal collecting venules, which are primary targets of leukocyte-endothelial interactions during reperfusion.
There are many factors that cause the degranulation of IMMC. Besides immunization, Kelley 20 found that oxidative stress made IMMC degranulation. Frossi 21 reported that oxidative stress can induce a pro-type 2 inflammatory response from mast cells resulting in mast cells degranulation. In the present study, intestinal ischemia and reperfusion was accompanied by the increasing MDA and decreasing activity of SOD. There was a positive correlation between the SOD activity and the concentration of histamine, indicating that oxide can induce IMMC degranulation and enhance ischemia-reperfusion injury.
Astragalus membranaceus is a traditional Chinese medicine which improves microcirculation and has a good curative effect. The results of our study showed that small intestinal mucosa was severely injured after simple hemorrhagic shock. However, the injury of small intestinal villus was alleviated after Astragalus membranaceus injection treatment. We found MDA content decreased while SOD activity increased after giving an Astragalus membranaceus injection, indicating the antioxdative effect of the Astragalus membranaceus injection. Better protection was obtained with high dose of Astragalus membranaceus treatment, indicating that Astragalus membranaceus injection protects intestinal mucosa against reperfusion injury in a dose-dependent manner. These results are consistent with our previous study. 7 In this study, we found that the ultrastructure of IMMC was near to normal and the expression of tryptase, IMMC counts and TNF-α concentration were normalized after the treatment with Astragalus membranaceus injection. There was a positive correlation between the SOD activity and the concentration of histamine in the four groups, indicating that Astragalus membranaceus injection can clear the oxygen radicals which induce IMMC degranulation and reduce reperfusion injury after hemorrhagic shock.
In conclusion, IMMC degranulation is associated with reperfusion injury after hemorrhagic shock. Astragalus membranaceus injection protects intestinal mucosa against hemorrhagic-reperfusion injury in a dose-dependant manner by stabilizing the IMMC and clearing the oxygen radicals.
